The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model - Krendyukov, A; Kneisel, N; Zhu, J; Merz, C; Richards, D; Gieffers, C; Van Den Eynde, B (Elsevier, 2020)